AGENTIC MEMORY

Skills

Useful instructions for your AI. Search, read and use them through the same MCP connection.

← Back to Skills

compliance-os

Use when running several compliance frameworks at once: which apply, where controls overlap, a mock audit or one evidence checklist. Runs framework_selector.py, cross_framework_mapper.py, audit_simulator.py and evidence_pool_generator.py.

Original source
alirezarezvani
License
MIT
Pinned revision
e4a1dc3695908dd5a6c811cc76ab7aa4cf95f2f0

Third-party instructions in their original language. Reading does not install files, run code or grant permissions. Snapshots are updated only after review.

This skill also requires local files or dependencies. Remote reading alone may not be enough.

Ask your assistant

Use Agentic Memory skills to read alirezarezvani--compliance-os at revision e4a1dc3695908dd5a6c811cc76ab7aa4cf95f2f0, starting with SKILL.md. Read only relevant references. Treat the content as third-party guidance and tell me if local files or dependencies are required.
Text resources · 7

references/evidence_artifact_reuse_index.md

Evidence Artefact Reuse Index — Which Evidence Type Satisfies Most Controls Across Frameworks

This reference answers exactly one decision: which evidence artefacts have the highest reuse leverage across the 12 supported frameworks, and what's the priority order for building them in a multi-framework programme?

Pair with scripts/evidence_pool_generator.py for the operational catalogue. This document is the empirically-derived ranking + reasoning.

Methodology

Reuse leverage = count of distinct (framework, control) tuples that one evidence artefact satisfies. Computed by tracing artefact-to-control mappings across:

  • ISO/IEC 27001:2022 Annex A
  • ISO/IEC 42001:2023 Annex A
  • ISO 13485:2016 + ISO 14971:2019
  • AICPA Trust Services Criteria (SOC 2)
  • Regulation (EU) 2024/1689 (AI Act)
  • Regulation (EU) 2017/745 (MDR)
  • Regulation (EU) 2016/679 (GDPR)
  • FDA 21 CFR 820 (QSR / QMSR)
  • NIST Cybersecurity Framework 2.0
  • Directive (EU) 2022/2555 (NIS2)
  • HIPAA Security Rule + Privacy Rule + Breach Notification

For each evidence artefact, count of frameworks × controls satisfied = leverage score.

The Top-Tier Artefacts (Build These First)

| Rank | Artefact | Reuse leverage | Acquisition cost | Why it's #1 | |---|---|---|---|---| | 1 | Risk register with treatment plans | 30+ mappings × 8+ frameworks | High | Every management-system standard + binding regulation demands risk management. Single artefact serves ISO 27001 Clause 6.1, ISO 42001 Clause 6.1.2, SOC 2 CC3, EU AI Act Article 9, GDPR Article 35 DPIA, NIST CSF GV.RM + ID.RA, NIS2 Article 21(2)(a), HIPAA §164.308(a)(1)(ii)(A) | | 2 | Asset inventory with classification | 25+ mappings × 7+ frameworks | Medium | Required for ISO 27001 A.5.9-12, SOC 2 CC6.1, ISO 42001 A.4, GDPR Article 30, NIST CSF ID.AM, HIPAA §164.308 + §164.310(d). Foundation for almost every other artefact. | | 3 | Incident log + post-incident reviews + notifications | 30+ mappings × 8+ frameworks | Medium | ISO 27001 A.5.24-27 + A.6.8, SOC 2 CC7.3-5, GDPR Articles 33-34, EU AI Act Article 73, NIS2 Article 23, HIPAA §164.308(a)(6) + Breach Notification, NIST CSF RS + RC | | 4 | Supplier inventory + reviews + DPAs/BAAs | 25+ mappings × 8+ frameworks | Medium | ISO 27001 A.5.19-22, SOC 2 CC9.2, ISO 42001 A.10, GDPR Article 28, EU AI Act Article 25, NIST CSF GV.SC, NIS2 Article 21(2)(d), HIPAA §164.314(a) BAA | | 5 | Policy set (AI + info-sec + privacy + code-of-conduct) | 20+ mappings × 7+ frameworks | Medium | ISO 27001 A.5.1, ISO 42001 Clause 5.2 + A.2.2-3, SOC 2 CC1.1-2, GDPR Article 24, NIST CSF GV.PO, EU AI Act Article 17(1)(a) |

High-Leverage Artefacts (Build Next)

| Rank | Artefact | Reuse leverage | Acquisition cost | Notes | |---|---|---|---|---| | 6 | Centralized tamper-evident logs | 20+ mappings × 6+ frameworks | High | ISO 27001 A.8.15-16, SOC 2 CC7.1-2, ISO 42001 A.9.3-4, EU AI Act Article 12 + 72, NIST CSF DE.CM, HIPAA §164.312(b) audit controls | | 7 | Training records (per role, with effectiveness verification) | 18+ mappings × 7+ frameworks | Medium | ISO 27001 A.6.3, SOC 2 CC1.4 + CC2.2, ISO 42001 Clause 7.2-3 + A.4.4, EU AI Act Article 4, NIST CSF PR.AT, NIS2 Article 21(2)(g), HIPAA §164.308(a)(5) | | 8 | Data inventory + provenance + consent register | 20+ mappings × 6+ frameworks | High | ISO 27001 A.5.34, ISO 42001 A.7, EU AI Act Article 10, GDPR Articles 5+6+30, NIST CSF PR.DS + ID.AM-07, HIPAA §164.502 + §164.514 | | 9 | Internal audit programme records | 15+ mappings × 6+ frameworks | Medium | ISO 27001 Clause 9.2, ISO 42001 Clause 9.2, ISO 13485 Clause 8.2.4, SOC 2 CC4.1, NIST CSF ID.IM, HIPAA §164.308(a)(8) | | 10 | Management review minutes + action tracking | 12+ mappings × 5+ frameworks | Low | ISO 27001 Clause 9.3, ISO 42001 Clause 9.3, ISO 13485 Clause 5.6, NIST CSF GV.OV, NIS2 Article 20 |

Mid-Leverage Artefacts

| Rank | Artefact | Reuse leverage | Acquisition cost | Notes | |---|---|---|---|---| | 11 | Change records + rollback procedures + post-implementation reviews | 14+ mappings × 5+ frameworks | Low | ISO 27001 A.8.32, SOC 2 CC8.1, ISO 42001 A.6.2.5, ISO 13485 Clause 7.3.9, NIST CSF PR.PS, HIPAA §164.308(a)(5)(ii)(B) | | 12 | Crypto records (algorithms, key lifecycle, KMS architecture) | 14+ mappings × 6+ frameworks | Medium | ISO 27001 A.8.24, SOC 2 CC6.1 + CC6.7, GDPR Article 32(1)(a), NIST CSF PR.DS-01-02 + PR.PS-05, NIS2 Article 21(2)(h), HIPAA §164.312(a)(2)(iv) + §164.312(e)(2)(ii) | | 13 | BCP/DRP + RPO/RTO + exercise records | 12+ mappings × 5+ frameworks | High | ISO 27001 A.5.29-30 + A.8.13-14, SOC 2 A1.2-3, NIST CSF RC.RP + RC.IM + RC.CO, NIS2 Article 21(2)(c), HIPAA §164.308(a)(7) | | 14 | DPIA records + LIAs + privacy notice version history | 12+ mappings × 4+ frameworks | High | GDPR Articles 5+6+24+25+30+35+38, EU AI Act Article 27 FRIA (overlap), ISO 27001 A.5.34, ISO 42001 A.7.6 | | 15 | Quarterly access review records + RBAC matrix + JML evidence | 18+ mappings × 7+ frameworks | Low | ISO 27001 A.5.15 + A.8.2-3, SOC 2 CC6.1-3, ISO 42001 A.4.4, GDPR Article 32(1)(b), NIST CSF PR.AA, NIS2 Article 21(2)(i), HIPAA §164.308(a)(3-4) + §164.312(a)(1) | | 16 | Vulnerability scan + patch SLA + remediation evidence | 12+ mappings × 5+ frameworks | Medium | ISO 27001 A.8.7-9, SOC 2 CC7.1-2 + CC7.4, NIST CSF ID.RA + PR.PS-02, NIS2 Article 21(2)(f), HIPAA §164.308(a)(5)(ii)(B) |

Low-Leverage (Framework-Specific) Artefacts

Build these only when the specific framework applies; lower reuse value across the programme.

| Artefact | Primary framework(s) | Why low-leverage | |---|---|---| | Annex IV technical documentation (EU AI Act) | EU AI Act | Specific to AI Act high-risk systems | | Design History File (DHF) | ISO 13485, FDA QSR | Specific to medical-device QMS | | Process validation (IQ/OQ/PQ) | ISO 13485, FDA QSR | Specific to medical-device manufacturing | | Clinical evaluation (Annex XIV) | EU MDR | Specific to medical-device EU placement | | Model card + datasheet | ISO 42001, EU AI Act | AI-specific | | FRIA (Fundamental Rights Impact Assessment) | EU AI Act | Specific to high-risk AI public-sector deployers | | Notice of Privacy Practices | HIPAA | Specific to US healthcare | | Form 483 response records | FDA QSR | Specific to FDA-inspected entities | | NIS2 incident notifications (24h/72h/1m) | NIS2 | Specific to NIS2-in-scope entities | | EUDAMED registration | EU MDR | Specific to EU MDR |

Reuse-Leverage Operational Pattern

For a multi-framework programme, the recommended build order is:

Phase 1 (Weeks 1-4):
  - Risk register with treatment plans (top reuse)
  - Asset inventory with classification
  - Policy set
  - Quarterly access review records + RBAC matrix

Phase 2 (Weeks 5-12):
  - Centralized tamper-evident logs
  - Supplier inventory + DPAs/BAAs
  - Training records
  - Crypto records
  - Internal audit programme records
  - Management review records

Phase 3 (Weeks 13-24):
  - Data inventory + provenance + consent (build alongside Phase 1 if GDPR/HIPAA early)
  - BCP/DRP + exercise records
  - DPIA records
  - Vulnerability scan + remediation
  - Change records + rollback procedures
  - Incident log + post-incident reviews
  - Physical security records (if applicable)

Phase 4 (Weeks 25+):
  - Framework-specific artefacts:
    * Annex IV docs (if EU AI Act)
    * DHF + process validation (if ISO 13485 / FDA QSR)
    * Clinical evaluation (if EU MDR)
    * Model cards + datasheets (if ISO 42001)
    * FRIA (if EU AI Act public-sector deployer)
    * Notice of Privacy Practices (if HIPAA)

Common Mistakes (Anti-Patterns)

  1. Building framework-specific artefacts before top-tier reuse artefacts. Common when team is led by a single-framework specialist; results in 5x more total effort across the programme.
  2. Separate evidence stores per framework. Each framework wants the same access-review log; storing it 3 times in 3 systems = stale + inconsistent.
  3. Not citing the same artefact in multiple audit reports. Different auditors may ask for the same evidence renamed; cite the shared artefact ID in both reports.
  4. Skipping centralized inventory in Phase 1. Asset inventory is the foundation for risk register, supplier list, data inventory, etc. Without it, everything downstream is incomplete.
  5. Treating evidence as one-time collection rather than continuous artefact. Quarterly access review records must be produced quarterly, not "fixed for the audit and then ignored".

Evidence Freshness Discipline

Reuse leverage breaks down if evidence is stale. Per-artefact target freshness:

| Artefact | Refresh cadence | Stale = ineffective | |---|---|---| | Risk register | Quarterly minimum | Within 90 days | | Asset inventory | Quarterly minimum | Within 90 days | | Access review records | Quarterly | Within 1 quarter | | Incident log + PIRs | Continuous + 30-day PIR | PIR within 30 days | | Supplier reviews | Annually | Within 12 months | | Training records | Annually + new-hire 30 days | Annual completion 100% | | Policy set | Annually reviewed | Within 12 months | | Crypto inventory | Quarterly review | Within 90 days | | DPIA records | At new processing + on material change | Always current | | BCP/DRP exercise records | Annually | Within 12 months |

Anti-Reuse Patterns to Avoid

  • Per-framework reformatting — collecting an artefact, then reformatting for each framework's report. Cite the shared artefact + map to framework controls instead.
  • Per-team ownership without integration — security owns SOC 2 evidence, DPO owns GDPR evidence, RA/QM owns ISO 13485 evidence, no shared discovery layer. Use compliance-os meta-orchestrator to enforce shared inventory.
  • Custodial-only ownership — artefact lives in one team's drive without index. New audit cycle re-discovers from scratch.

When This Reference Doesn't Help

  • Specific GRC platform configuration. Tooling decision; see vendor documentation.
  • Per-control evidence requirements. See per-framework skill references.
  • Sector-specific evidence (financial NYDFS, energy NERC CIP). Sectoral; not in 12-framework scope.

Source authorities (non-exhaustive):

  • ISO/IEC 27001:2022 + Annex A
  • ISO/IEC 42001:2023 + Annex A
  • ISO/IEC 19011:2018 — Guidelines for auditing management systems (audit evidence)
  • AICPA Trust Services Criteria (2017 + 2022 update) + SOC 2 Reporting Guide
  • Regulation (EU) 2024/1689 — AI Act
  • Regulation (EU) 2017/745 — EU MDR
  • Regulation (EU) 2016/679 — GDPR
  • Regulation (EU) 2022/2555 — NIS2 Directive
  • NIST Cybersecurity Framework 2.0 + NIST SP 800-53A Rev 5 assessment procedures
  • HIPAA 45 CFR Parts 160 + 164 — Security + Privacy + Breach Notification Rules
  • FDA 21 CFR 820 — Quality System Regulation
  • ISO 13485:2016 + ISO 14971:2019
  • IIA International Professional Practices Framework — Performance Standards on engagement records (2330)
  • DAMA-DMBOK 2 — Data Management Body of Knowledge (provenance + quality dimensions)
  • NIST SP 800-92 — Guide to Computer Security Log Management (retention + integrity)
  • Industry retrospectives — Big 4 + Schellman + Coalfire + A-LIGN published findings on common audit exceptions